Liechtenstein vs Saint Kitts and Nevis: Current health expenditure
Current health expenditure over time
- Liechtenstein
- Saint Kitts and Nevis
How they compare
Saint Kitts and Nevis currently reports 5.7% against 5.7% in Liechtenstein, a difference of 0.0%.
The two have swapped places 3 times across 11 shared years of data; in 2013 it was Liechtenstein ahead.
Liechtenstein ranks 111th and Saint Kitts and Nevis ranks 110th of 193 countries.
Across the 2 decades both report, Liechtenstein averaged higher in 1 and Saint Kitts and Nevis in 1.
Head to head by decade
| Decade | Liechtenstein | Saint Kitts and Nevis | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 5.7% | 5.1% | 0.6% | Liechtenstein |
| 2020s | 5.7% | 5.8% | 0.1% | Saint Kitts and Nevis |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher current health expenditure, Liechtenstein or Saint Kitts and Nevis?
- Saint Kitts and Nevis, at 5.7% against 5.7% in Liechtenstein as of 2023.
- What is the difference in current health expenditure between Liechtenstein and Saint Kitts and Nevis?
- 0.0%, with Saint Kitts and Nevis ahead.
- How many years of comparable data are there for Liechtenstein and Saint Kitts and Nevis?
- 11 years are reported by both, from 2013 to 2023.
- How do Liechtenstein and Saint Kitts and Nevis rank globally for current health expenditure?
- Liechtenstein ranks 111th and Saint Kitts and Nevis ranks 110th of 193 countries.
- Where does this data come from?
- Global Health Expenditure Database, updated December 12th, 2025, World Health Organization (WHO), published as Current health expenditure (% of GDP). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Level of current health expenditure expressed as a percentage of GDP. Estimates of current health expenditures include healthcare goods and services consumed during each year. This indicator does not include capital health expenditures such as buildings, machinery, IT and stocks of vaccines for emergency or outbreaks.